Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Li Xing, Hai-Tao Lv, San-Guang Liu, Wen-Bin Wang, Teng-Fei Zhang, Jian-Hua Liu & Wei Bian. (2021) The effect of gemcitabine combined with AMD3100 applying to cholangiocarcinoma RBE cell lines to CXCR4/CXCL12 axis. Scandinavian Journal of Gastroenterology 56:8, pages 914-919.
Read now
Read now
Antonio Cigliano, Xin Chen & Diego F. Calvisi. (2021) Current challenges to underpinning the genetic basis for cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 15:5, pages 511-526.
Read now
Read now
Daolin Ji, Wangyang Zheng, Peng Huang, Yue Yao, Xiangyu Zhong, Pengcheng Kang, Zhidong Wang, Guojing Shi, Yi Xu & Yunfu Cui. (2020) Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress. OncoTargets and Therapy 13, pages 7819-7837.
Read now
Read now
Guohe Lin, Bicheng Wang, Xiuwei Wu, Tong Sun, Lili Chen, Canliang Lu & Nianfei Wang. (2020) Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma. Cancer Management and Research 12, pages 11523-11526.
Read now
Read now
Qing Zhao, Sheng Qian, Liang Zhu, Xu-Dong Qu, Wei Zhang, Zhi-Ping Yan, Jie-Min Cheng, Qing-Xin Liu, Rong Liu & Jian-Hua Wang. (2015) Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer. OncoTargets and Therapy 8, pages 595-600.
Read now
Read now
Tae Won Kwak, Hee Jae Shin, Young-Il Jeong, Myoung-Eun Han, Sae-Ock Oh, Hyun-Jung Kim, Do Hyung Kim & Dae Hwan Kang. (2015) Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma. Drug Design, Development and Therapy 9, pages 2201-2214.
Read now
Read now
Articles from other publishers (49)
Megumi Nishitani Yukuyama, Aline de Souza, Mirla Anali Bazán Henostroza, Gabriel Lima Barros de Araujo, Raimar Löbenberg, Rafael de Oliveira Faria, Gabriel Batista de Souza, Lara Mendes Ferreira Guimaraes, Claudiana Lameu, Beatriz Rabelo Folchini, Camilla Midori Peroni, Isabela Fernandes Oliveira, Mariana Yasue Saito Miyagi & Nádia Araci Bou-Chacra. (2023) Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment. Journal of Drug Delivery Science and Technology 89, pages 105017.
Crossref
Crossref
Akihiro Kitagawa, Tsuyoshi Osawa, Miwa Noda, Yuta Kobayashi, Sho Aki, Yusuke Nakano, Tomoko Saito, Dai Shimizu, Hisateru Komatsu, Maki Sugaya, Junichi Takahashi, Keisuke Kosai, Seiichiro Takao, Yushi Motomura, Kuniaki Sato, Qingjiang Hu, Atsushi Fujii, Hiroaki Wakiyama, Taro Tobo, Hiroki Uchida, Keishi Sugimachi, Kohei Shibata, Tohru Utsunomiya, Shogo Kobayashi, Hideshi Ishii, Takanori Hasegawa, Takaaki Masuda, Yusuke Matsui, Atsushi Niida, Tomoyoshi Soga, Yutaka Suzuki, Satoru Miyano, Hiroyuki Aburatani, Yuichiro Doki, Hidetoshi Eguchi, Masaki Mori, Keiichi I. Nakayama, Teppei Shimamura, Tatsuhiro Shibata & Koshi Mimori. (2023) Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma. British Journal of Cancer 128:12, pages 2206-2217.
Crossref
Crossref
Linde Kehmann, Marie-Luise Berres, Maria Gonzalez-Carmona, Dominik P. Modest, Raphael Mohr, Alexander Wree, Marino Venerito, Christian Strassburg, Verena Keitel, Christian Trautwein, Tom Luedde & Christoph Roderburg. (2023) Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC). BMC Cancer 23:1.
Crossref
Crossref
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang & Nariman Nezami. (2023) Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15:9, pages 2624.
Crossref
Crossref
Yu-Qing Zhang, Kang Wang, Jin-Kai Feng, Lu-Yun Yuan, Chao Liang, Yan-Jun Xiang, Xu Wang, Fei-Fei Mao & Shu-Qun Cheng. (2023) Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study. Frontiers in Oncology 13.
Crossref
Crossref
Jinbao Lai, Songlin Yang, Zhuying Lin, Wenwen Huang, Xiao Li, Ruhong Li, Jing Tan & Wenju Wang. (2023) Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies. American Journal of Clinical Oncology 46:4, pages 131-141.
Crossref
Crossref
Paulina Chmiel, Katarzyna Gęca, Karol Rawicz-Pruszyński, Wojciech P. Polkowski & Magdalena Skórzewska. (2022) FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?. Cells 11:23, pages 3929.
Crossref
Crossref
Shanshan Weng, Ding Zhang, Mengyuan Yang, Liuhong Wang & Ying Yuan. (2022) Vemurafenib effectively controlled Chemotherapy-refractory Intrahepatic Cholangiocarcinoma with BRAF V600E Mutation: a case report and literature review. Zeitschrift für Gastroenterologie 60:12, pages 1787-1791.
Crossref
Crossref
Kecheng Zhang, Hu Liu, Yongyang Zhao & Baohua Zhang. (2022) The clinical outcomes of extended resections in patients with IV stage gallbladder cancers: A retrospective study from a large tertiary center. Frontiers in Oncology 12.
Crossref
Crossref
Yanshen Chen, Hua Liu, Qiaowei Zheng, Houli Li, Huining You, Yan Feng & Weiyi Feng. (2022) Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin. Life Sciences 306, pages 120826.
Crossref
Crossref
Ellen J. Spartz, Matthew Wheelwright, Tetyana Mettler, Khalid Amin, Nabeel Azeem, Mohamed Hassan, Jacob Ankeny & James V. Harmon. (2022) Evaluation of abnormal gallbladder imaging findings: Surgical management and pathologic correlations in early‐stage gallbladder cancer. Clinical Case Reports 10:7.
Crossref
Crossref
O. Mirallas, D. López-Valbuena, D. García-Illescas, C. Fabregat-Franco, H. Verdaguer, J. Tabernero & T. Macarulla. (2022) Advances in the systemic treatment of therapeutic approaches in biliary tract cancer. ESMO Open 7:3, pages 100503.
Crossref
Crossref
Goro Ueno, Yoshifumi Iwagami, Shogo Kobayashi, Suguru Mitsufuji, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh, Masaki Mori, Yuichiro Doki & Hidetoshi Eguchi. (2022) ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer. Annals of Surgical Oncology 29:5, pages 2899-2909.
Crossref
Crossref
Magdalena Rogalska-Taranta & Jesper B. Andersen. (2022) Involvement of Epigenomic Factors in Bile Duct Cancer. Seminars in Liver Disease 42:02, pages 202-211.
Crossref
Crossref
Yanhua Wu, Khizar Hayat, Yufei Hu & Jianfeng Yang. (2022) Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Biao Zhang, Shuang Li, Zhao-Yi Liu, Karieshinie Ghandalie Kalandika Peiris, Li-Fu Song, Mu-Cang Liu, Peng Luo, Dong Shang & Wei Bi. (2022) Successful multimodality treatment of metastatic gallbladder cancer: A case report and review of literature. World Journal of Clinical Cases 10:12, pages 3856-3865.
Crossref
Crossref
Miguel Zugman, Gehan Botrus, Roberto Carmagnani Pestana & Pedro Luiz Serrano Uson Junior. (2022) Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives. Frontiers in Oncology 12.
Crossref
Crossref
Yuting Pan, Hanyan Si, Ru Jia, Guochao Deng, Huan Yan, Mengjia Fan, Miaomiao Gou, Shiyun Chen, Nan Zhang, Yue Shi, Niansong Qian & Guanghai Dai. (2022) Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Yuto Hozaka, Yota Kawasaki, Satoshi Iino, Tetsuya Idichi, Yuki Hirase, Kiyonori Tanoue, Yuko Mataki, Hiroshi Kurahara, Kosei Maemura, Takaaki Arigami, Shinichi Ueno, Shoji Natsugoe & Takao Ohtsuka. (2021) Locally advanced cholangiolocellular carcinoma successfully treated with curative resection after downsizing chemotherapy: a case report. Surgical Case Reports 7:1.
Crossref
Crossref
Yingnan Yang, Zhuolong Tu, Chentao Ye, Huajie Cai, Shouzhang Yang, Xuehai Chen & Jinfu Tu. (2021) Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surgery 21:1.
Crossref
Crossref
Huayuan Liu, Caiyun Liu, Mengya Wang, Dongxu Sun, Pengcheng Zhu, Ping Zhang, Xueying Tan & Guangjun Shi. (2021) Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. Scientific Reports 11:1.
Crossref
Crossref
Alberto Zanetto, Sarah Shalaby, Martina Gambato, Giacomo Germani, Marco Senzolo, Debora Bizzaro, Francesco Paolo Russo & Patrizia Burra. (2021) New Indications for Liver Transplantation. Journal of Clinical Medicine 10:17, pages 3867.
Crossref
Crossref
Nabanita Roy, Mrinmoy Kshattry, Susmita Mandal, Mohit Kumar Jolly, Dhruba Kumar Bhattacharyya & Pankaj Barah. (2021) An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis. Journal of Clinical Medicine 10:16, pages 3520.
Crossref
Crossref
Robert Czarnomysy, Dominika Radomska, Olga Klaudia Szewczyk, Piotr Roszczenko & Krzysztof Bielawski. (2021) Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments. International Journal of Molecular Sciences 22:15, pages 8271.
Crossref
Crossref
Mauro Stefano, Enrico Prosperi, Paola Fugazzola, Beatrice Benini, Marcello Bisulli, Federico Coccolini, Costantino Mastronardi, Alessandro Palladino, Matteo Tomasoni, Vanni Agnoletti, Emanuela Giampalma & Luca Ansaloni. (2021) Case Report: Cytoreductive Surgery and HIPEC Associated With Liver Electrochemotherapy in a Cholangiocarcinoma Patient With Peritoneal Carcinomatosis and Liver Metastasis Case Report. Frontiers in Surgery 8.
Crossref
Crossref
Xiaohong Pu, Qing Ye, Jing Cai, Xin Yang, Yao Fu, Xiangshan Fan, Hongyan Wu, Jun Chen, Yudong Qiu & Shen Yue. (2021) Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. Cell Death & Disease 12:3.
Crossref
Crossref
Alexander Scheiter, Felix Keil, Florian Lüke, Jirka Grosse, Niklas Verloh, Sabine Opitz, Sophie Schlosser, Arne Kandulski, Tobias Pukrop, Wolfgang Dietmaier, Matthias Evert, Diego F. Calvisi & Kirsten Utpatel. (2021) Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Current Oncology 28:2, pages 1161-1169.
Crossref
Crossref
Fan-li Zeng & Jing-fang Chen. (2021) Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma. Technology in Cancer Research & Treatment 20, pages 153303382110399.
Crossref
Crossref
Reham Abdel-Wahab, Timothy A. Yap, Russell Madison, Shubham Pant, Matthew Cooke, Kai Wang, Haitao Zhao, Tanios Bekaii-Saab, Elif Karatas, Lawrence N. Kwong, Funda Meric-Bernstam, Mitesh Borad & Milind Javle. (2020) Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer. Scientific Reports 10:1.
Crossref
Crossref
Qi Li, Qifan Zhang, Xiao Cheng, Xie Weng, Mian Chen, Xiaoyun Hu, Jing Huang & Jinzhang Chen. (2020) Next-Generation Sequencing Characterizes the Landscape of Somatic Mutations and Pathways in Metastatic Bile Tract Carcinoma. Journal of Oncology 2020, pages 1-8.
Crossref
Crossref
Xiaohong Pu, Liya Zhu, Feng Li, Jinyu Zheng, Hongyan Wu, Yao Fu, Jun Chen & Liang Qi. (2020) Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology - Research and Practice 216:9, pages 153116.
Crossref
Crossref
Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo-Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni & Massimo Aglietta. (2020) Evolution of the Experimental Models of Cholangiocarcinoma. Cancers 12:8, pages 2308.
Crossref
Crossref
Yan Zhu & Lawrence N. Kwong. (2020) Insights Into the Origin of Intrahepatic Cholangiocarcinoma From Mouse Models. Hepatology 72:1, pages 305-314.
Crossref
Crossref
Ying Fu, Daniel J. Urban, Roger R. Nani, Yi‐Fan Zhang, Nan Li, Haiying Fu, Hamzah Shah, Alexander P. Gorka, Rajarshi Guha, Lu Chen, Matthew D. Hall, Martin J. Schnermann & Mitchell Ho. (2019) Glypican‐3‐Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma. Hepatology 70:2, pages 563-576.
Crossref
Crossref
Phorutai Pearngam, Supeecha Kumkate, Seiji Okada & Tavan Janvilisri. (2019) Andrographolide Inhibits Cholangiocarcinoma Cell Migration by Down-Regulation of Claudin-1 via the p-38 Signaling Pathway. Frontiers in Pharmacology 10.
Crossref
Crossref
Emilien Loeuillard, Samantha R. Fischbach, Gregory J. Gores & Sumera Rizvi. (2019) Animal models of cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865:5, pages 982-992.
Crossref
Crossref
F. Rassam, E. Roos, K. P. van Lienden, J. E. van Hooft, H. J. Klümpen, G. van Tienhoven, R. J. Bennink, M. R. Engelbrecht, A. Schoorlemmer, U. H. W. Beuers, J. Verheij, M. G. Besselink, O. R. Busch & T. M. van Gulik. (2018) Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbeck's Archives of Surgery 403:3, pages 289-307.
Crossref
Crossref
Wei Song, Dong-Liu Miao & Lei Chen. (2018) Survival rates are higher in married patients with biliary tract cancer: a population-based study. Oncotarget 9:10, pages 9531-9539.
Crossref
Crossref
Julia Delahousse, Loic Verlingue, Sophie Broutin, Clémence Legoupil, Mehdi Touat, Ludovic Doucet, Samy Ammari, Ludovic Lacroix, Michel Ducreux, Jean-Yves Scoazec, David Malka, Angelo Paci & Antoine Hollebecque. (2018) Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas. European Journal of Cancer 90, pages 83-91.
Crossref
Crossref
Min Su You, Sang Hyub Lee, Jinwoo Kang, Young Hoon Choi, Jin Ho Choi, Woo Hyun Paik, Ji Kon Ryu & Yong-Tae Kim. (2018) Metastatic Gallbladder Cancer Treated with Curative Surgery after Cyclic Chemotherapy and Biliary Drainage. The Korean Journal of Pancreas and Biliary Tract 23:1, pages 41-47.
Crossref
Crossref
Lin-hua Zhou & Xiao-feng Luo. (2017) Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis. Clinica Chimica Acta 474, pages 102-107.
Crossref
Crossref
Ting-Ting Pan, Wei Wang, Wei-Dong Jia & Ge-Liang Xu. (2017) A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma. Oncology Letters 13:5, pages 2957-2964.
Crossref
Crossref
Hamzeh Kayhanian, Elizabeth C Smyth & Chiara Braconi. (2017) Emerging molecular targets and therapy for cholangiocarcinoma. World Journal of Gastrointestinal Oncology 9:7, pages 268.
Crossref
Crossref
Prashant Sukharamwala, Daniel Hennessey, Thomas Wood, Shelly Singh, Carrie Ryan & Alexander Rosemurgy. (2016) Molecular profiles in foregut oncology. Cancer Genetics 209:12, pages 537-553.
Crossref
Crossref
Chandragouda Dodagoudar, Dinesh Chandra Doval, Anupam Mahanta, Varun Goel, Amitabh Upadhyay, Pankaj Goyal, Vineet Talwar, Sajjan Singh, Mithun Chacko John, Srikant Tiwari & Nivedita Patnaik. (2016) FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Japanese Journal of Clinical Oncology 46:1, pages 57-62.
Crossref
Crossref
Malte Kokoschka, Jakub Galgonek, Jiri Vondrasek & Pavel Hobza. (2016) Computational methods for the description of pharmacologically relevant platinum complexes – molecular structure and bond dissociation. Physical Chemistry Chemical Physics 18:5, pages 4051-4062.
Crossref
Crossref
Yi-An Zhang, Xi-Zhong Shen, Ji-Min Zhu & Tao-Tao Liu. (2015) Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis. Medicine 94:45, pages e2052.
Crossref
Crossref
Hyun-Jin Nam, Hwang-Phill Kim, Young-Kwang Yoon, Sang-Hyun Song, Ah-Rum Min, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh & Yung-Jue Bang. (2011) The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines. Investigational New Drugs 30:6, pages 2148-2160.
Crossref
Crossref
Masakuni Fujii, Hirofumi Kawamoto & Kazuhide Yamamoto. (2010) Evidence-based guidelines for the management of biliary tract cancer. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 122:3, pages 249-251.
Crossref
Crossref